Literature DB >> 19951712

CK beta 8/CCL23 induces cell migration via the Gi/Go protein/PLC/PKC delta/NF-kappa B and is involved in inflammatory responses.

Jeonghan Kim1, Yoon Suk Kim, Jesang Ko.   

Abstract

AIMS: CKbeta8/CCL23 is a CC chemokine and alternative splicing of the CKbeta8 gene produces two mRNAs that encode CKbeta8 and its isoform CKbeta8-1. Although it has been reported that CKbeta8 and CKbeta8-1 are implicated in leukocyte trafficking and development of inflammation, the exact roles of these two chemokines in immune responses and the associated chemotaxis signaling are still obscure. MAIN
METHODS: To understand the mechanism of CKbeta8- and CKbeta8-1-induced chemotaxis signaling, we examined the chemotactic activities of osteogenic sarcoma cells expressing CC chemokine receptor 1 in response to CKbeta8 and CKbeta8-1. We also examined involvement of CKbeta8 and CKbeta8-1 in inflammatory responses by determining the mRNA expression of pro-inflammatory molecules induced by two chemokines and expressions of these chemokines in foam cells. KEY
FINDINGS: Results from a chemotaxis assay using various inhibitors for signaling molecules showed that the chemotaxis signal pathway induced by both CKbeta8 and CKbeta8-1 was mediated via the G(i)/G(o) protein, phospholipase C (PLC) and protein kinase Cdelta (PKCdelta). Treatment with a nuclear factor kappaB (NF-kappaB) inhibitor reduced the chemotactic activities of CKbeta8 and CKbeta8-1, and NF-kappaB was activated in response to CKbeta8 and CKbeta8-1. In addition, CKbeta8 and CKbeta8-1 increased mRNA expression of pro-inflammatory cytokines and adhesion molecules. The mRNA levels of CKbeta8 and CKbeta8-1 were increased in foam cells. SIGNIFICANCE: These results indicate that both CKbeta8 and CKbeta8-1 transduce the chemotaxis signal through the G(i)/G(o) protein, PLC, PKCdelta, and NF-kappaB, and that CKbeta8 and CKbeta8-1 probably play important roles in inflammatory diseases such as atherosclerosis. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951712     DOI: 10.1016/j.lfs.2009.11.012

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Potential involvement of CCL23 in atherosclerotic lesion formation/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes.

Authors:  Chu-Sook Kim; Ji-Hye Kang; Hong-Rae Cho; Thomas N Blankenship; Kent L Erickson; Teruo Kawada; Rina Yu
Journal:  Inflamm Res       Date:  2011-06-09       Impact factor: 4.575

2.  Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancer.

Authors:  Kalika Kamat; Venkatesh Krishnan; Oliver Dorigo
Journal:  Br J Cancer       Date:  2022-06-24       Impact factor: 9.075

3.  CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Júlia Faura; Alejandro Bustamante; Anna Penalba; Dolors Giralt; Alba Simats; Elena Martínez-Sáez; Daniel Alcolea; Juan Fortea; Alberto Lleó; Charlotte E Teunissen; Wiesje M van der Flier; Laura Ibañez; Oscar Harari; Carlos Cruchaga; Mar Hernández-Guillamón; Pilar Delgado; Joan Montaner
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Juglanthraquinone C Induces Intracellular ROS Increase and Apoptosis by Activating the Akt/Foxo Signal Pathway in HCC Cells.

Authors:  Ya-Qin Hou; Yao Yao; Yong-Li Bao; Zhen-Bo Song; Cheng Yang; Xiu-Li Gao; Wen-Jing Zhang; Lu-Guo Sun; Chun-Lei Yu; Yan-Xin Huang; Guan-Nan Wang; Yu-Xin Li
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

5.  A multi-stage association study of plasma cytokines identifies osteopontin as a biomarker for acute coronary syndrome risk and severity.

Authors:  Kuai Yu; Binyao Yang; Haijing Jiang; Jun Li; Kai Yan; Xuezhen Liu; Lue Zhou; Handong Yang; Xiulou Li; Xinwen Min; Ce Zhang; Xiaoting Luo; Wenhua Mei; Shunchang Sun; Liyun Zhang; Xiang Cheng; Meian He; Xiaomin Zhang; An Pan; Frank B Hu; Tangchun Wu
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

Review 6.  Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy.

Authors:  Michellie Thurman; Samuel Johnson; Arpan Acharya; Suresh Pallikkuth; Mohan Mahesh; Siddappa N Byrareddy
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

7.  Proteomic changes in intracranial blood during human ischemic stroke.

Authors:  Benton Maglinger; Jacqueline A Frank; Christopher J McLouth; Amanda L Trout; Jill Marie Roberts; Stephen Grupke; Jadwiga Turchan-Cholewo; Ann M Stowe; Justin F Fraser; Keith R Pennypacker
Journal:  J Neurointerv Surg       Date:  2020-07-08       Impact factor: 5.836

8.  Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line.

Authors:  Chen-Lu Wu; Shui-Ping Zhao; Bi-Lian Yu
Journal:  Lipids Health Dis       Date:  2013-12-17       Impact factor: 3.876

9.  Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease.

Authors:  Christopher R Heier; Alyson A Fiorillo; Ellen Chaisson; Heather Gordish-Dressman; Yetrib Hathout; Jesse M Damsker; Eric P Hoffman; Laurie S Conklin
Journal:  Clin Transl Gastroenterol       Date:  2016-09-15       Impact factor: 4.488

10.  Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro.

Authors:  Lin Shi; Ning Zhang; Hetao Liu; Lei Zhao; Jing Liu; Juan Wan; Wenyi Wu; Hetian Lei; Rongqing Liu; Mei Han
Journal:  Mol Med Rep       Date:  2018-01-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.